全球非侵入性產前檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

非侵入性產前檢測 (NIPT) 市場預計將從 2025 年的 60.9 億美元成長到 2034 年的 203 億美元，預計從 2026 年到 2034 年將以 14.31% 的複合年成長率成長。

由於人們對早期發現胎兒遺傳異常重要性的認知不斷提高，全球無創產前檢測 (NIPT) 市場正經歷顯著成長。 NIPT 為侵入性檢測提供了一種安全、準確的替代方案，最大限度地降低了母嬰雙方的風險。人們對早期診斷和預防醫學日益成長的興趣，在推動 NIPT 的全球普及方面發揮著至關重要的作用。

基因測序技術的進步和平均生育年齡的上升是推動市場成長的關鍵因素，後者增加了染色體異常的風險。政府推行的產前篩檢和改善醫療保健服務的措施也促進了市場擴張。此外，新興國家醫療保健意識的提高也有助於提高篩檢的普及率。

未來，檢測能力的提升可望使更多類型的遺傳疾病得以檢測。價格的降低和可近性的提高將進一步擴大其應用範圍。隨著醫療系統優先考慮早期和非侵入性診斷，非侵入性產前檢測（NIPT）很可能成為全球產前保健的標準流程。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球非侵入性產前檢測市場：依產品及服務分類

• 市場分析、洞察與預測
• 產品
• 服務

第5章 全球無創產前檢測市場：依檢測方法分類

• 市場分析、洞察與預測
• 超音波檢查
• 生化篩檢試驗
• 母體血漿遊離DNA檢測

第6章 全球非侵入性產前檢測市場：依應用領域分類

• 市場分析、洞察與預測
• 三體症候群
• 微缺失症候群
• 其他

第7章 全球非侵入性產前檢測市場：依檢測類型分類

• 市場分析、洞察與預測
• Materni21
• Harmony
• Panorama'
• Verify
• NIFTY
• 其他

第8章 全球非侵入性產前檢測市場：依技術分類

• 市場分析、洞察與預測
• NGS
• WGS
• 其他

第9章 全球無創產前檢測市場：依最終用戶分類

• 市場分析、洞察與預測
• 診斷檢查室
• 醫院

第10章：全球無創產前檢測市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第11章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第12章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Illumina Inc
  • Thermo Fisher Scientific Inc
  • General Electric
  • BGI Group
  • Agilent Technologies Inc
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer Inc
  • Laboratory Corporation Of America Holdings
  • Natera Inc
  • Yourgene Health
  • Eurofins LifeCodexx GmbH

The Noninvasive Prenatal Testing Market size is expected to reach USD 20.30 Billion in 2034 from USD 6.09 Billion (2025) growing at a CAGR of 14.31% during 2026-2034.

The global noninvasive prenatal testing (NIPT) market is growing significantly due to increasing awareness about early detection of fetal genetic abnormalities. NIPT provides a safe and accurate alternative to invasive procedures, minimizing risks for both mother and fetus. The growing emphasis on early diagnosis and preventive healthcare has played a key role in driving adoption globally.

Key drivers include advancements in genomic sequencing technologies and the rising average maternal age, which increases the risk of chromosomal disorders. Government initiatives promoting prenatal screening and improved access to healthcare services are also supporting market expansion. Additionally, increasing healthcare awareness in emerging economies is contributing to higher adoption rates.

In the future, the market is expected to witness advancements in testing capabilities, enabling detection of a broader range of genetic conditions. Improved affordability and accessibility will further expand its reach. As healthcare systems prioritize early and noninvasive diagnostics, NIPT is likely to become a standard practice in prenatal care worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product and Services

• Products
• Services

By Method

• Ultrasound Detection
• Biochemical Screening Test
• Cell-Free DNA in Maternal Plasma Tests

By Application

• Trisomy
• Microdeletion Syndrome
• Other

By Test Type

• Materni21
• Harmony
• Panorama
• Verify
• NIFTY
• Others

By Technology

• NGS
• WGS
• Others

By End User

• Diagnostic Laboratories
• Hospitals

COMPANIES PROFILED

• Illumina Inc, Thermo Fisher Scientific Inc, General Electric, BGI Group, Agilent Technologies Inc, F HoffmannLa Roche Ltd, PerkinElmer Inc, Laboratory Corporation of America Holdings, Natera Inc, Yourgene Health, Eurofins LifeCodexx GmbH
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NONINVASIVE PRENATAL TESTING MARKET: BY PRODUCT AND SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Services
• 4.2. Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NONINVASIVE PRENATAL TESTING MARKET: BY METHOD 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Method
• 5.2. Ultrasound Detection Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biochemical Screening Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cell-Free DNA in Maternal Plasma Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NONINVASIVE PRENATAL TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Trisomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Microdeletion Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NONINVASIVE PRENATAL TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Test Type
• 7.2. Materni21 Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Harmony Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Panorama Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Verify Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. NIFTY Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL NONINVASIVE PRENATAL TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Technology
• 8.2. NGS Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. WGS Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL NONINVASIVE PRENATAL TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End User
• 9.2. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL NONINVASIVE PRENATAL TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Product And Services
  • 10.2.2 By Method
  • 10.2.3 By Application
  • 10.2.4 By Test Type
  • 10.2.5 By Technology
  • 10.2.6 By End User
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Product And Services
  • 10.3.2 By Method
  • 10.3.3 By Application
  • 10.3.4 By Test Type
  • 10.3.5 By Technology
  • 10.3.6 By End User
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Product And Services
  • 10.4.2 By Method
  • 10.4.3 By Application
  • 10.4.4 By Test Type
  • 10.4.5 By Technology
  • 10.4.6 By End User
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Product And Services
  • 10.5.2 By Method
  • 10.5.3 By Application
  • 10.5.4 By Test Type
  • 10.5.5 By Technology
  • 10.5.6 By End User
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Product And Services
  • 10.6.2 By Method
  • 10.6.3 By Application
  • 10.6.4 By Test Type
  • 10.6.5 By Technology
  • 10.6.6 By End User
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL NONINVASIVE PRENATAL TESTING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Illumina Inc
  • 12.2.2 Thermo Fisher Scientific Inc
  • 12.2.3 General Electric
  • 12.2.4 BGI Group
  • 12.2.5 Agilent Technologies Inc
  • 12.2.6 F. Hoffmann-La Roche Ltd
  • 12.2.7 PerkinElmer Inc
  • 12.2.8 Laboratory Corporation Of America Holdings
  • 12.2.9 Natera Inc
  • 12.2.10 Yourgene Health
  • 12.2.11 Eurofins LifeCodexx GmbH